Prevalence of gastroesophageal reflux disorder in arrhythmic patients and adjunctive effects of proton pump inhibitors on comorbid atrial fibrillation.

Odashiro, Keita; Yasuda, Shioto; Yokoyama, Taku; Yoda, Shunsuke; Noda, Hirotaka; Fukata, Mitsuhiro; Arita, Takeshi; Maruyama, Toru; Akashi, Koichi.
Artículo en Inglés | IMSEAR | ID: sea-165155

Documentos relacionados

  1. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases.
  2. Frontiers in Endoscopic Treatment for Gastroesophageal Reflux Disease.
  3. Association of residual gastric acid secretion with persistent symptoms in gastroesophageal reflux disease patients receiving standard-dose proton pump inhibitor therapy.
  4. AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review.
  5. Short and long term effect of anti-reflux mucosectomy with cap-assisted endoscopic mucosal resection for refractory gastroesophageal disease.
  6. Long-term efficacy of antireflux mucosectomy in patients with refractory gastroesophageal reflux disease.
  7. Transoral incisionless fundoplication with an ultrasonic surgical endostapler for the treatment of gastroesophageal reflux disease: 12-month outcomes.
  8. Gastroesophageal reflux disease after peroral endoscopic myotomy is unpredictable, but responsive to proton pump inhibitor therapy: a large, single-center study.
  9. The early therapeutic response at 2 weeks is a crucial predictor of proton pump inhibitor-refractory gastroesophageal reflux disease.
  10. Endoscopic Non-ablative Radiofrequency Treatment (Stretta) for Gastroesophageal Reflux Disease (GERD).